MAPK3 and plasma cell myeloma: CCN1-dependent signaling pathways were not involved mechanistically in this pro-myeloma effect as no alterations in phosphorylated p38, ERK1/2, and STAT3 by CCN1 treatment of INA-6 cells was observed.